1. Abstract History taking is the first interaction with the patient and is very important step and in concordance with clinical features and investigations in making final diagnosis of disease of patient. The proper diagnosis is a chain reaction which starts with detailed history followed by clinical examination and in last relevant investigations are done …
Missing Links in History Leads to Diagnostic Dilemma Read More »
1. Abstract 1.1. Introduction: Chronic Hepatitis C Virus (HCV) infection, a leading cause of liver cirrhosis, causes significant morbidity and mortality and has become an important indication for liver transplantation all over the world. The initial treatment was with Pegylated Interferon and Ribavarin but later on wide availability of oral Directly Acting Antiviral (DAA) drugs …
1. Abstract 1.1. Background: Several patient, government, payer, and provider-level barriers to Hepatitis C virus (HCV) treatment have been identified in regions like Asia, Africa, and the Commonwealth of Independent States (CIS). A patient registry was created in these regions to understand the patterns of clinical care and outcomes in real-world settings.
1. Abstract 1.1. Background: Often patients with carcinomas of esophagus presents with dysphagia at a late stage where curative treatments are not a treatment option. To relieve dysphagia and its consequences palliative esophageal stentings are offered. Self-expanding metal stents (SEMS) and self-expanding plastic stents (SEPS) are available for reliving the dysphagia. Uncovered, partially covered, or …
Self-expandable Metallic Stents for the Palliation of Malignant Growth of Esophagus Read More »
1. Summary Primary cystic duct adenocarcinomas is rare amongst the extrahepatic bile duct malignancy. Moreso it has a very difficult preoperative diagnosis and is diagnosed intraoperatively or postoperatively. It has a better prognosis compared to other extrahepatic biliary tumours. We describe a case which was preoperatively diagnosed as carcinoma neck of gall bladder, intraoperatively showing …
A Rare Case of Primary Cystic Duct Adenocarcinoma Read More »
1. Summary In primary myelofibrosis (PM), it is rare to observe PH by intrahepatic block secondary to hepatic myeloid metaplasia. Its diagnosis is histological based on liver biopsy. Splenomegaly and hepatomegaly are the main signs found at the beginning of the disease, while ascites and digestive hemorrhage are complications that cloud the prognosis. The etiological …
1. Abstract 1.1. Introduction: A gastric diverticulum is a rare form of diverticular disease due to outpouching of the gastric wall. The rates of detection vary depending upon the method used to detect them. Occasionally, complications, such as ulceration, upper gastro intestinal bleeding, hemorrhage, perforation, and malignant transformation, can develop that may be life-threatening and …
A large Gastric Diverticulum: A Rare Endoscopic Finding Read More »
1. Abstract 1.1. Background: Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) is a transcription factor that regulates the expression of the cellular antioxidant response. Traditionally, Nrf2 is regarded as a tumor suppressor owing to its characteristic which prevents oxidative or electrophilic insult. However, there is increasing evidence that Nrf2 is activated in malignant cells. At …
1. Abstract 1.1. Background: Colorectal cancer liver metastases (CRLM) that cannot be surgically removed are often addressed locally with Hepatic Arterial Infusion (HAI) or Selective Internal Radiation Therapy (SIRT). This study used Bayesian network meta-analysis (NMA) to assess the differences in survival between patients treated with HAI or SIRT for CRLM.
1. Abstract 1.1. Background: Colorectal cancer liver metastases (CRLM) that cannot be surgically removed are often addressed locally with Hepatic Arterial Infusion (HAI) or Selective Internal Radiation Therapy (SIRT). This study used Bayesian network meta-analysis (NMA) to assess the differences in survival between patients treated with HAI or SIRT for CRLM.
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.